Latest News and Press Releases
Want to stay updated on the latest news?
-
Dublin, Jan. 06, 2026 (GLOBE NEWSWIRE) -- The "The Global Nanobubbles Market 2026-2036" report has been added to ResearchAndMarkets.com's offering. The Global Nanobubbles Market Report 2026-2036...
-
Dublin, Jan. 06, 2026 (GLOBE NEWSWIRE) -- The "2025 Global Marketplaces Report" report has been added to ResearchAndMarkets.com's offering. Transactions are no longer optional - they're the...
-
Chicago, Jan. 06, 2026 (GLOBE NEWSWIRE) -- The global cell and gene therapy market was valued at US$ 36.5 billion in 2025 and is expected to reach US$ 183.1 billion by 2035, growing at a CAGR of...
-
BMB-101 demonstrated significant anti-seizure benefit in both cohorts with favorable safety and tolerability Absence: 73.1% median reduction in the number of absence seizure ≥3s, p = 0.012DEE: 63.3%...
-
- Róbert Wessman to continue serving as Executive Chairman in full-time capacity - Lisa Graver appointed Chief Executive Officer REYKJAVIK, Iceland, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Alvotech...
-
Róbert Wessman to continue serving as Executive Chairman in full-time capacityLisa Graver appointed Chief Executive Officer REYKJAVIK, ICELAND (January 6, 2026) — Alvotech (NASDAQ: ALVO), a global...
-
HONG KONG, Jan. 06, 2026 (GLOBE NEWSWIRE) -- It’s been a banner year for Hong Kong’s restaurant, bar and hospitality scene. Fresh off its historic achievement, in which venues in Hong Kong became...
-
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.KEY...
-
FREDERICK, Md., Jan. 06, 2026 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering cell therapy for autoimmune diseases,...
-
ITASCA, Ill., Jan. 06, 2026 (GLOBE NEWSWIRE) -- Riverside Insights, a leading provider of trusted, research-backed assessments, today announced a new international distribution partnership with...
-
RESEARCH TRIANGLE PARK, N.C., Jan. 06, 2026 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the compensation committee of BioCryst’s board of directors granted...
-
BURLINGTON, Mass., Jan. 06, 2026 (GLOBE NEWSWIRE) -- Fractyl Health, Inc. (Nasdaq: GUTS) (the “Company” or “Fractyl”), a metabolic therapeutics company focused on pattern-breaking approaches that...
-
WATERTOWN, Mass., Jan. 06, 2026 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader...
-
Papa Johns and the CHL® Launch “Champions of Tomorrow” to Support Canada’s Young Hockey Players with $25,000 scholarship across Canada.
-
NEW YORK, Jan. 06, 2026 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Maple Gold...
-
BETHESDA, Md., Jan. 06, 2026 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of...
-
Key Mining Corp. (“KMC” or the “Company”) is a global critical minerals and infrastructure company focused on acquiring, advancing and developing assets in the Americas with projects in Chile and the...
-
Orlando, FL, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Coda Octopus Group, Inc. (“CODA” or the “Company”) (NASDAQ: CODA), a global market leader in real-time 3D/4D/5D and 6D imaging sonar technology for...
-
FDA clearance enables initiation of Abpro’s first clinical-stage solid tumor program Clinical trial anticipated to commence in the first half of 2026 through Abpro’s global collaboration with...
-
Funnel closes a landmark year, playing a central role in helping the largest operators translate centralization and AI into exceptional renter experiences.
-
Crown Crafts to Participate in the ICR Conference
-
Alumis’ Envudeucitinib Delivers Leading Skin Clearance Among Next-Generation Oral Plaque Psoriasis Therapies in Phase 3 Program
-
VANCOUVER, British Columbia, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Anfield Energy Inc. (TSX.V: AEC; NASDAQ: AEC; FRANKFURT: 0AD) (“Anfield” or the “Company”), a leading U.S.-focused uranium and vanadium...
-
SHENZHEN, China, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Aurora Mobile Limited (NASDAQ: JG) ("Aurora Mobile" or the "Company"), a leading provider of customer engagement and marketing technology services...
-
Vancouver, British Columbia, Jan. 06, 2026 (GLOBE NEWSWIRE) -- NevGold Corp. (“NevGold” or the “Company”) (TSXV:NAU) (OTCQX:NAUFF) (Frankfurt:5E50) is pleased to announce positive, consistent...
-
DURHAM, N.C., Jan. 06, 2026 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), today announced that CEO Anshul Thakral, CFO Jill McConnell, and SVP of...
-
Lead program ALE1 for hypophosphatasia (HPP) progressing through the clinic with a Ph1/2a study currently ongoing in healthy volunteers; HPP patients expected to be dosed in H1 2026 Second...
-
Instil Bio’s Subsidiary Discontinues Clinical Development of AXN-2510 and Terminates License and Collaboration Agreement with ImmuneOnco
-
BERKELEY HEIGHTS, N.J., Jan. 06, 2026 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a fully integrated, commercial biotechnology company, announced...
-
Austin, Texas, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Vocal Biomarkers Market Size & Growth Analysis: According to SNS Insider, The Vocal Biomarkers Market size was valued at USD 1.59 billion in...
-
HOUSTON, Jan. 06, 2026 (GLOBE NEWSWIRE) -- via IBN -- Envirotech Vehicles, Inc. (NASDAQ:EVTV) ("EVTV" or the "Company") today announced that it has entered into an Amended and Restated Letter of...
-
AUSTIN, Texas, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Digital Realty (NYSE: DLR), the largest global provider of cloud- and carrier-neutral data center, colocation, and interconnection solutions,...
-
MENLO PARK, Calif., Jan. 06, 2026 (GLOBE NEWSWIRE) -- Oruka Therapeutics, Inc. (“Oruka”) (Nasdaq: ORKA), a clinical stage biotechnology company developing novel biologics designed to set a new...
-
Fischer Imaging moves toward commercialization of the innovative MammoCAT Digital Mammography System by presenting at RESI JPM 2026 IPC on 1/12/2026.
-
NEW YORK, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of the beverage, cannabis and...
-
MONROE TOWNSHIP, N.J., Jan. 06, 2026 (GLOBE NEWSWIRE) -- Ocean Power Technologies, Inc. (“OPT” or “the Company”) (NYSE American: OPTT), a leader in innovative and cost-effective low-carbon marine...
-
BitMart launches its Prediction Market, enabling USDT-based trading on crypto, sports, and event outcomes with real-time probability pricing.
-
Transpire Bio today announced that it successfully dosed the first human subject with its experimental drug candidate in a novel inhalation formulation.
-
The Evotrex-PG5 delivers advanced energy generation, intelligent power management, and a premium, durable design engineered to enable travelers to roam farther and stay longerThe RV trailer is on...
-
Data demonstrate clinical translation of VOWST mechanisms of action in both first and multiply recurrent CDI patients Seres MbTx® platform provides high-resolution functional biological understanding...
-
PyroGenesis Signs Agreement with U.S. Defense Contractor to Jointly Pursue Chemical Weapon Destruction Contracts in Syria.
-
Givastomig, a CLDN18.2 x 4-1BB bispecific antibody, continues to show robust efficacy when combined with nivolumab and chemotherapy (mFOLFOX6) in 1L HER2-negative, metastatic gastric cancer patients,...
-
Transaction Provides Greater Financial Flexibility to Drive Long-Term GrowthEliminates Annual Preferred Dividend of $18 MillionStrengthens Corporate Governance and Realignment Among Stockholders ...
-
RESEARCH TRIANGLE PARK, N.C., Jan. 06, 2026 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company plans to present at the 44th Annual J.P. Morgan...
-
BOSTON, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (Atea or Company), a clinical-stage biopharmaceutical company engaged in the discovery and development of oral...
-
DALLAS, Jan. 06, 2026 (GLOBE NEWSWIRE) -- P10, Inc. (NYSE: PX), (“P10” or the “Company”), a leading private markets solutions provider, today announced the opening of a new office in Dubai, located...
-
LAKESHORE, Ontario, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Boralex inc. (“Boralex”) (TSX: BLX), in partnership with Walpole Island First Nation, announces the commercial commissioning of Sanjgon Battery...
-
SLINGERLANDS, N.Y., Jan. 06, 2026 (GLOBE NEWSWIRE) -- Plug Power Inc. (NASDAQ: PLUG), a global leader in comprehensive hydrogen solutions for the hydrogen economy, announce its participation in...
-
LAS VEGAS, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Lantronix Inc. (NASDAQ: LTRX), a global leader in compute and connectivity IoT solutions powering Edge AI applications, today announced the debut of its...
-
NEW YORK, Jan. 06, 2026 (GLOBE NEWSWIRE) -- LB Pharmaceuticals, Inc (“LB Pharmaceuticals” or the “Company”) (Nasdaq: LBRX), a clinical-stage biopharmaceutical company developing novel therapies for...